Micelle-based nanoparticles with stimuli-responsive properties for drug delivery
Cancer treatment often causes adverse effects and toxicity, as chemotherapy drugs affect both cancerous and healthy cells. Scientists seek to target tumor cells specifically and minimize harm to normal cells. Smart nanoparticles (NPs) are a modern technique that can release drugs when triggered by internal or external stimuli, such as temperature, pH, ultrasound, etc. This review covers stimuli-responsive micelle-based nanoparticles (SRM-NPs), a promising drug delivery platform that can enhance drug efficacy and reduce toxicity. It discusses the recent developments and applications of SRM-NPs, their responsiveness to different stimuli, and their potential to overcome drug resistance and adaptive responses. It also addresses the challenges and issues related to their stability, reproducibility, biocompatibility, safety, and optimization. The study concludes that SRM-NPs have great potential for drug delivery, but more research and development are needed to improve their clinical utility.
History
Data Availability Statement
Data sharing is not applicable for this article as no datasets were generated or analyzed during the current study.Comments
The original article is available at https://www.degruyter.com/Published Citation
Maboudi AH. et al. Micelle-based nanoparticles with stimuli-responsive properties for drug delivery. Nanotechnol Rev. 2024;13(1):20230218Publication Date
11 March 2024External DOI
Department/Unit
- School of Pharmacy and Biomolecular Sciences
Publisher
De GruyterVersion
- Published Version (Version of Record)